Home » Topics » BioWorld Science

BioWorld Science
RSS

Apogenix working towards conditional MAA submission for asunercept in E.U.

May 24, 2018

NIAID initiates phase I study of SeVRSV vaccine

May 24, 2018

European Commission approves Sandoz's infliximab biosimilar Zessly

May 24, 2018

Bicycle Therapeutics expands collaboration with AstraZeneca

May 24, 2018

MIW-815 elicits strong and durable cancer immunity

May 24, 2018

Esperion's third pivotal study of bempedoic acid meets primary endpoint

May 24, 2018

DSMB recommends continuation of phase II study of Xanamem in Alzheimer's disease

May 24, 2018

Clinical results reported for bifunctional short-hairpin RNA for Ewing's sarcoma

May 24, 2018

Targeting TGF-beta-1 prevents pulmonary fibrosis in rats

May 24, 2018

FDA approves Yonsa for metastatic CRPC

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...